The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
New insights into ovarian cancer pathology
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stewart, B. W., & Kleihues, P. (2003) · Cited by 2,386
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
Kurman, R. J., & Shih, I.-M. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf3d79 · Cited by 1,846
ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas
Wiegand, K. C., Shah, S. P., Al-Agha, O. M., Zhao, Y., Tse, K., Zeng, T., Senz, J., McConechy, M. K., Anglesio, M. S., Kalloger, S. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1008433 · Cited by 1,712
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
Tothill, R. W., Tinker, A. V., George, J., Brown, R., Fox, S. B., Lade, S., Johnson, D. S., Trivett, M. K., Etemadmoghadam, D., Locandro, B., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0196 · Cited by 1,467
Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors
Esteller, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.564 · Cited by 1,233
Kindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S., Feltmate, C., Medeiros, F., Callahan, M. J., Garner, E. O., Gordon, R. W., Birch, C., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213335.40358.47 · Cited by 1,113
du Bois, A. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg036 · Cited by 1,113
Medeiros, F., Muto, M. G., Lee, Y., Elvin, J. A., Callahan, M. J., Feltmate, C., Garber, J. E., Cramer, D. W., & Crum, C. P. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000180854.28831.77 · Cited by 916
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Lee, Y., Miron, A., Drapkin, R., Nucci, M., Medeiros, F., Saleemuddin, A., Garber, J., Birch, C., Mou, H., Gordon, R., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2091 · Cited by 898
Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma
Singer, G., Oldt, R., Cohen, Y., Wang, B. G., Sidransky, D., Kurman, R. J., & Shih, I.-M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.484 · Cited by 854
Walker, R. A. (2005) · Histopathology · doi:10.1111/j.1365-2559.2004.02026.x · Cited by 839
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Köbel, M., Kalloger, S. E., Boyd, N., McKinney, S., Mehl, E., Palmer, C., Leung, S., Bowen, N. J., Ionescu, D. N., Rajput, A., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050232 · Cited by 814 · cited 1×
“CCCs are usually positive for HNF1-β (>90%) and are negative for ER and WT1 in >95% of cases [21, 30].”
BackgroundSugiyama, T., Kamura, T., Kigawa, J., Terakawa, N., Kikuchi, Y., Kita, T., Suzuki, M., Sato, I., & Taguchi, K. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2584::aid-cncr22>3.0.co;2-5 · Cited by 795
Piek, J. M. J., van Diest, P. J., Zweemer, R. P., Jansen, J. W., Poort‐Keesom, R. J. J., Menko, F. H., Gille, J. J. P., Jongsma, A. P. M., Pals, G., Kenemans, P., et al. (2001) · The Journal of Pathology · doi:10.1002/path.1000 · Cited by 787
Risch, H. A., McLaughlin, J. R., Cole, D. E. C., Rosen, B., Bradley, L., Fan, I., Tang, J., Li, S., Zhang, S., Shaw, P. A., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj465 · Cited by 680
Grading Ovarian Serous Carcinoma Using a Two-Tier System
Malpica, A., Deavers, M. T., Lu, K., Bodurka, D. C., Atkinson, E. N., Gershenson, D. M., & Silva, E. G. (2004) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200404000-00009 · Cited by 670
Prat, J. (2012) · Virchows Archiv · doi:10.1007/s00428-012-1203-5 · Cited by 602
Self-citationSato, N., Tsunoda, H., Nishida, M., Morishita, Y., Takimoto, Y., Kubo, T., & Noguchi, M. (2000) · PubMed · doi:10.11501/3187985 · Cited by 448
The genesis and evolution of high-grade serous ovarian cancer
Bowtell, D. D. L. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2946 · Cited by 445
Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
OBATA, K., Morland, S. J., Watson, R. H., Hitchcock, A., Chenevix‐Trench, G., Thomas, E. J., & Campbell, I. (1998) · PubMed · Cited by 429
Singer, G., Stöhr, R., Cope, L., Dehari, R., Hartmann, A., Cao, D.-F., Wang, T.-L., Kurman, R. J., & Shih, I.-M. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000146025.91953.8d · Cited by 408
Mutations in the beta-catenin gene (CTNNB1) in endometrioid ovarian carcinomas.
Palacios, J., & Gamallo, C. (1998) · PubMed · Cited by 407
Lee, K. R. C. K., & Scully, R. E. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200011000-00001 · Cited by 343
Folkins, A. K., Jarboe, E. A., Saleemuddin, A., Lee, Y., Callahan, M. J., Drapkin, R., Garber, J. E., Muto, M. G., Tworoger, S., & Crum, C. P. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.01.012 · Cited by 293
Clinical Behavior of Stage II-IV Low-Grade Serous Carcinoma of the Ovary
Gershenson, D. M., Sun, C. C., Lu, K. H., Coleman, R. L., Sood, A. K., Malpica, A., Deavers, M. T., Silva, E. G., & Bodurka, D. C. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000227787.24587.d1 · Cited by 290
Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities
Press, J. Z., De Luca, A., Boyd, N., Young, S., Troussard, A., Ridge, Y., Kaurah, P., Kalloger, S. E., Blood, K. A., Smith, M., et al. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-17 · Cited by 287
Serous Carcinogenesis in the Fallopian Tube: A Descriptive Classification
Jarboe, E., Folkins, A., Nucci, M. R., Kindelberger, D., Drapkin, R., Miron, A., Lee, Y., & Crum, C. P. (2008) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31814b191f · Cited by 273
Histologic Transformation of Benign Endometriosis to Early Epithelial Ovarian Cancer
Sainz de la Cuesta, R., Eichhorn, J. H., Rice, L. W., Fuller, Jr., Nikrui, N., & Goff, B. A. (1996) · Gynecologic Oncology · doi:10.1006/gyno.1996.0032 · Cited by 272
Takano, M., Kikuchi, Y., Yaegashi, N., Kuzuya, K., Ueki, M., Tsuda, H., Suzuki, M., Kigawa, J., Takeuchi, S., Tsuda, H., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603116 · Cited by 266
Köbel, M., Kalloger, S. E., Carrick, J., Huntsman, D., Asad, H., Oliva, E., Ewanowich, C. A., Soslow, R. A., & Gilks, C. B. (2009) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181788546 · Cited by 231
Kato, N., Sasou, S.-I., & Motoyama, T. (2006) · Modern Pathology · doi:10.1038/modpathol.3800492 · Cited by 226
β-Catenin Expression Pattern in Stage I and II Ovarian Carcinomas
Gamallo, C., Palacios, J., Moreno, G., Calvo de Mora, J., Suárez, A., & Armas, A. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65148-6 · Cited by 220
Low‐grade serous carcinomas of the ovary contain very few point mutations
Jones, S., Wang, T., Kurman, R. J., Nakayama, K., Velculescu, V. E., Vogelstein, B., Kinzler, K. W., Papadopoulos, N., & Shih, I. (2012) · The Journal of Pathology · doi:10.1002/path.3967 · Cited by 218
Rodríguez, I. M., & Prat, J. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200202000-00001 · Cited by 218
Self-citationAllelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage.
Jiang, X., Morland, S. J., Hitchcock, A., Thomas, E. J., & Campbell, I. (1998) · PubMed · Cited by 207
Linking the Cellular Functions of BRCA Genes to Cancer Pathogenesis and Treatment
Venkitaraman, A. R. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.3.121806.151422 · Cited by 203
Catasús, L., Bussaglia, E., Rodrı́guez, I., Gallardo, A., Pons, C., Irving, J. A., & Prat, J. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.07.019 · Cited by 181
Self-citationMoreno‐Bueno, G., Gamallo, C., Pérez–Gallego, L., de Mora, J. C., Suárez, A., & Palacios, J. (2001) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200106000-00008 · Cited by 148
Frequency of BRCA1 Dysfunction in Ovarian Cancer
Geisler, J. P. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.1.61 · Cited by 141
A distinct molecular profile associated with mucinous epithelial ovarian cancer
Heinzelmann-Schwarz, V. A., Gardiner‐Garden, M., Henshall, S. M., Scurry, J., Scolyer, R. A., Smith, A. N., Bali, A., Bergh, P. M. V., Baron-Hay, S. E., Scott, C. D., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603003 · Cited by 137
Genetic Analysis of the Early Natural History of Epithelial Ovarian Carcinoma
Pothuri, B., Leitão, M. M., Levine, D. A., Viale, A. J., Olshen, A. B., Arroyo, C. D., Bogomolniy, F., Olvera, N., Lin, O., Soslow, R. A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010358 · Cited by 128
Irving, J. A., Catasús, L., Gallardo, A., Bussaglia, E., Romero, M., Matías‐Guiu, X., & Prat, J. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.03.005 · Cited by 124
Self-citationKomiyama, S., Aoki, D., Tominaga, E., Susumu, N., Udagawa, Y., & Nozawa, S. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1998.5284 · Cited by 119
Norquist, B. M., Garcia, R. L., Allison, K. H., Jokinen, C. H., Kernochan, L. E., Pizzi, C. C., Barrow, B. J., Goff, B. A., & Swisher, E. M. (2010) · Cancer · doi:10.1002/cncr.25439 · Cited by 108
The Role of Hepatocyte Nuclear Factor-1A in the Pathogenesis of Clear Cell Carcinoma of the Ovary
Kobayashi, H., Yamada, Y., Kanayama, S., Furukawa, N., 野口, 武., Haruta, S., Yoshida, S., Sakata, M., Sado, T., & Oi, H. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181a19eca · Cited by 68
Expression of ?-glutamyl cysteine synthetase in nonsmall cell lung carcinoma
Soini, Y., T�rm�nen-N�p�nkangas, U., J�rvinen, K., Kaarteenaho–Wiik, R., P��kk�, P., & Kinnula, V. L. (2001) · Cancer · doi:10.1002/1097-0142(20011201)92:11<2829::aid-cncr10094>3.0.co;2-3 · Cited by 40
Summary and discussion of session recommendations
Trimble, E. L., Fountain, J. W., & Birrer, M. J. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.08.022 · Cited by 26
Cited by
Ovarian cancer statistics, 2018
Torre, L. A., Trabert, B., DeSantis, C. E., Miller, K. D., Samimi, G., Runowicz, C. D., Gaudet, M. M., Jemal, A., & Siegel, R. L. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21456 · Cited by 3,492
Lheureux, S., Gourley, C., Vergote, I., & Oza, A. M. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32552-2 · Cited by 1,919
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
Lheureux, S., Braunstein, M., & Oza, A. M. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21559 · Cited by 1,423
NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 4.2016
Ettinger, D. S., Wood, D. E., Akerley, W., Bazhenova, L. A., Borghaei, H., Camidge, D. R., Cheney, R. T., Chirieac, L. R., D'Amico, T. A., Dilling, T. J., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0031 · Cited by 736
NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022: Featured Updates to the NCCN Guidelines
Armstrong, D. K., Alvarez, R. D., Backes, F. J., Bakkum-Gamez, J. N., Barroilhet, L., Behbakht, K., Berchuck, A., Chen, L.-M., Chitiyo, V. C., Cristea, M., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0047 · Cited by 401
Metadata
- Authors
- Prat, J.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 23
- Pages
- x111-x117
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2121741947
- Cited by
- 317
- References
- 47
- FWCI
- 17.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.